Geode Capital Management, LLC Sonoma Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 35,780 shares of SNOA stock, worth $8,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,780
Previous 35,780
-0.0%
Holding current value
$8,229
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SNOA
# of Institutions
17Shares Held
164KCall Options Held
0Put Options Held
0-
Susquehanna International Group, LLP Bala Cynwyd, PA46.1KShares$10,5910.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$5,5920.0% of portfolio
-
Xtx Topco LTD London, X016.5KShares$3,7860.0% of portfolio
-
Two Sigma Securities, LLC New York, NY13.5KShares$3,0980.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny13KShares$2,9930.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $713K
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...